TD Waterhouse Canada Inc. Buys 5,765 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

TD Waterhouse Canada Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 25.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,416 shares of the medical equipment provider's stock after acquiring an additional 5,765 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in Intuitive Surgical were worth $14,831,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in ISRG. Howard Capital Management Group LLC boosted its holdings in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock valued at $1,044,000 after buying an additional 92 shares during the period. Principal Financial Group Inc. boosted its stake in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock valued at $295,938,000 after acquiring an additional 9,194 shares during the period. World Investment Advisors LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at approximately $228,000. Arvest Bank Trust Division acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $260,000. Finally, Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded up $6.46 on Friday, reaching $514.59. 2,015,889 shares of the company's stock traded hands, compared to its average volume of 1,614,267. The company has a market capitalization of $183.29 billion, a P/E ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00. The business's 50 day moving average price is $511.92 and its two-hundred day moving average price is $532.42.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the company earned $1.50 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the sale, the executive vice president now directly owns 2,245 shares of the company's stock, valued at $1,152,089.10. This trade represents a 43.09 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,454 shares of company stock worth $18,564,027 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Piper Sandler dropped their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday. Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Evercore ISI decreased their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday. Finally, Leerink Partners lifted their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $598.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.